Biomarkers of the dementia

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Shoji, Mikio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AUTOANTIBODY; BIOLOGICAL MARKER; HOMOCYSTEINE; TAU PROTEIN;

DEMENTIA; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; REVIEW; RISK FACTOR; SENSITIVITY AND SENSIBILITY;

EID: 80052669683     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/564321     Document Type: Review

References (40)

1. Petersen R. C., Aisen P. S., Beckett L. A., Donohue M. C., Gamst A. C., Harvey D. J., Jack C. R., Jagust W. J., Shaw L. M., Toga A. W., Trojanowski J. Q., Weiner M. W., Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization Neurology 2010 74 3 201 209
2. Shoji M., Kanai M., Cerebrospinal fluid A 40 and A 42: natural course and clinical usefulness Journal of Alzheimer's Disease 2001 3 3 313 321 (Pubitemid 32577635)
3. Shoji M., Kanai M., Matsubara E., Tomidokoro Y., Shizuka M., Ikeda Y., Ikeda M., Harigaya Y., Okamoto K., Hirai S., The levels of cerebrospinal fluid A 40 and A 42(43) are regulated age-dependently Neurobiology of Aging 2001 22 2 209 215 (Pubitemid 32162969)
4. Kanai M., Matsubara E., Isoe K., Urakami K., Nakashima K., Arai H., Sasaki H., Abe K., Iwatsubo T., Kosaka T., Watanabe M., Tomidokoro Y., Shizuka M., Mizushima K., Nakamura T., Igeta Y., Ikeda Y., Amari M., Kawarabayashi T., Ishiguro K., Harigaya Y., Wakabayashi K., Okamoto K., Hirai S., Shoji M., Longitudinal study of cerebrospinal fluid levels of tau, A 1-40, and A 1-42(43) in Alzheimer's disease: a study in Japan Annals of Neurology 1998 44 1 17 26 (Pubitemid 28323651)
5. Kang J. E., Lim M. M., Bateman R. J., Lee J. J., Smyth L. P., Cirrito J. R., Fujiki N., Nishino S., Holtzman D. M., Amyloid- dynamics are regulated by orexin and the sleep-wake cycle Science 2009 326 5955 1005 1007
6. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., McKay D. M., Tintner R., Frangione B., Younkin S. G., Production of the Alzheimer amyloid protein by normal proteolytic processing Science 1992 258 5079 126 129
7. Bateman R. J., Siemers E. R., Mawuenyega K. G., Wen G., Browning K. R., Sigurdson W. C., Yarasheski K. E., Friedrich S. W., DeMattos R. B., May P. C., Paul S. M., Holtzman D. M., A -secretase inhibitor decreases amyloid- production in the central nervous system Annals of Neurology 2009 66 1 48 54
8. Shoji M., Matsubara E., Murakami T., Manabe Y., Abe K., Kanai M., Ikeda M., Tomidokoro Y., Shizuka M., Watanabe M., Amari M., Ishiguro K., Kawarabayashi T., Harigaya Y., Okamoto K., Nishimura T., Nakamura YU., Takeda M., Urakami K., Adachi Y., Nakashima K., Arai H., Sasaki H., Kanemaru K., Yamanouchi H., Yoshida Y., Ichise K., Tanaka K., Hamamoto M., Yamamoto H., Matsubayashi T., Yoshida H., Toji H., Nakamura S., Hirai S., Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group Neurobiology of Aging 2002 23 3 363 370 (Pubitemid 34312018)
9. Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L., Eckman C., Golde T. E., Younkin S. G., An increased percentage of long amyloid protein secreted by familial amyloid protein precursor ( APP) mutants Science 1994 264 5163 1336 1340
10. Shoji M., Kanai M., Matsubara E., Ikeda M., Harigaya Y., Okamoto K., Hirai S., Taps to Alzheimer's patients: a continuous Japanese study of cerebrospinal fluid biomarkers [5] Annals of Neurology 2000 48 3 402
11. Hulstaert F., Blennow K., Ivanoiu A., Schoonderwaldt H. C., Riemenschneider M., De Deyn P. P., Bancher C., Cras P., Wiltfang J., Mehta P. D., Iqbal K., Pottel H., Vanmechelen E., Vanderstichele H., Improved discrimination of AD patients using -amyloid((1-42)) and tau levels in CSF Neurology 1999 52 8 1555 1562 (Pubitemid 29220627)
12. Knopman D. S., DeKosky S. T., Cummings J. L., Chui H., Corey-Bloom J., Relkin N., Small G. W., Miller B., Stevens J. C., Practice parameter: diagnosis of dementia (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology Neurology 2001 56 9 1143 1153 (Pubitemid 32405708)
13. Andreasen N., Minthon L., Davidsson P., Vanmechelen E., Vanderstichele H., Winblad B., Blennow K., Evaluation of CSF-tau and CSF-A 42 as diagnostic markers for Alzheimer disease in clinical practice Archives of Neurology 2001 58 3 373 379 (Pubitemid 32217453)
14. Clark C. M., Xie S., Chittams J., Ewbank D., Peskind E., Galasko D., Morris J. C., McKeel Jr. D. W., Farlow M., Weitlauf S. L., Quinn J., Kaye J., Knopman D., Arai H., Doody R. S., DeCarli C., Leight S., Lee V. M.-Y., Trojanowski J. Q., Cerebrospinal fluid tau and -amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Archives of Neurology 2003 60 12 1696 1702 (Pubitemid 37521622)
15. Sunderland T., Linker G., Mirza N., Putnam K. T., Friedman D. L., Kimmel L. H., Bergeson J., Manetti G. J., Zimmermann M., Tang B., Bartko J. J., Cohen R. M., Decreased -amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease Journal of the American Medical Association 2003 289 16 2094 2103 (Pubitemid 37430211)
16. Itoh N., Arai H., Urakami K., Ishiguro K., Ohno H., Hampel H., Buerger K., Wiltfang J., Otto M., Kretzschmar H., Moeller H. J., Imagawa M., Kohno H., Nakashima K., Kuzuhara S., Sasaki H., Imahori K., Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease Annals of Neurology 2001 50 2 150 156 (Pubitemid 32738138)
17. Hampel H., Buerger K., Zinkowski R., Teipel S. J., Goernitz A., Andreasen N., Sjoegren M., DeBernardis J., Kerkman D., Ishiguro K., Ohno H., Vanmechelen E., Vanderstichele H., McCulloch C., Mller H. J., Davies P., Blennow K., Measurement of phosphorylated tau epitopes in the differential diagnosis of alzheimer disease: a comparative cerebrospinal fluid study Archives of General Psychiatry 2004 61 1 95 102 (Pubitemid 38044645)
18. Blennow K., Hampel H., CSF markers for incipient Alzheimer's disease Lancet Neurology 2003 2 10 605 613 (Pubitemid 37162569)
19. Hampel H., Teipel S. J., Fuchsberger T., Andreasen N., Wiltfang J., Otto M., Shen Y., Dodel R., Du Y., Farlow M., Mller H. J., Blennow K., Buerger K., Value of CSF -amyloid and tau as predictors of Alzheimer's disease in patients with mild cognitive impairment Molecular Psychiatry 2004 9 7 705 710 (Pubitemid 38932175)
20. Parnetti L., Lanari A., Silvestrelli G., Saggese E., Reboldi P., Diagnosing prodromal Alzheimer's disease: role of CSF biochemical markers Mechanisms of Ageing and Development 2006 127 2 129 132 (Pubitemid 43165611)
21. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L., Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurology 2006 5 3 228 234 (Pubitemid 43238346)
22. Fagan A. M., Roe C. M., Xiong C., Mintun M. A., Morris J. C., Holtzman D. M., Cerebrospinal fluid tau/ -amyloid ratio as a prediction of cognitive decline in nondemented older adults Archives of Neurology 2007 64 3 343 349 (Pubitemid 46425688)
23. Shaw L. M., Vanderstichele H., Knapik-Czajka M., Clark C. M., Aisen P. S., Petersen R. C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V. M. Y., Trojanowski J. Q., Cerebrospinal fluid biomarker signature in alzheimer's disease neuroimaging initiative subjects Annals of Neurology 2009 65 4 403 413
24. Trojanowski J. Q., Vandeerstichele H., Korecka M., Clark C. M., Aisen P. S., Petersen R. C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W. Z., Weiner M. W., Jack Jr. C. R., Jagust W., Toga A. W., Lee V. M.-Y., Shaw L. M., Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects Alzheimer's and Dementia 2010 6 3 230 238
25. Apostolova L. G., Hwang K. S., Andrawis J. P., Green A. E., Babakchanian S., Morra J. H., Cummings J. L., Toga A. W., Trojanowski J. Q., Shaw L. M., Jack C. R., Petersen R. C., Aisen P. S., Jagust W. J., Koeppe R. A., Mathis C. A., Weiner M. W., Thompson P. M., 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects Neurobiology of Aging 2010 31 8 1284 1303
26. Nettiksimmons J., Harvey D., Brewer J., Carmichael O., DeCarli C., Jack C. R., Petersen R., Shaw L. M., Trojanowski J. Q., Weiner M. W., Beckett L., Subtypes based on cerebrospinal fluid and magnetic resonance imaging markers in normal elderly predict cognitive decline Neurobiology of Aging 2010 31 8 1419 1428
27. Okonkwo O. C., Alosco M. L., Griffith H. R., Mielke M. M., Shaw L. M., Trojanowski J. Q., Tremont G., Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease Archives of Neurology 2010 67 6 688 696
28. Mattsson N., Zetterberg H., Hansson O., Andreasen N., Parnetti L., Jonsson M., Herukka S. K., Van Der Flier W. M., Blankenstein M. A., Ewers M., Rich K., Kaiser E., Verbeek M., Tsolaki M., Mulugeta E., Rosén E., Aarsland D., Jelle Visser P., Schrder J., Marcusson J., De Leon M., Hampel H., Scheltens P., Pirttil T., Wallin A., Eriksdotter Jnhagen M., Minthon L., Winblad B., Blennow K., CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment Journal of the American Medical Association 2009 302 4 385 393
29. Visser P. J., Verhey F., Knol D. L., Scheltens P., Wahlund L. O., Freund-Levi Y., Tsolaki M., Minthon L., Wallin. K., Hampel H., Brger K., Pirttila T., Soininen H., Rikkert M. O., Verbeek M. M., Spiru L., Blennow K., Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study The Lancet Neurology 2009 8 7 619 627
30. Matsubara E., Ghiso J., Frangione B., Amari M., Tomidokoro Y., Ikeda Y., Harigaya Y., Okamoto K., Shoji M., Lipoprotein-free amyloidogenic peptides in plasma are elevated in patients with sporadic Alzheimer's disease and Down's syndrome Annals of Neurology 1999 45 4 537 541 (Pubitemid 29165825)
31. van Oijen M., Hofman A., Soares H. D., Koudstaal P. J., Breteler M. M., Plasma A 1-40 and A 1-42 and the risk of dementia: a prospective case-cohort study Lancet Neurology 2006 5 8 655 660 (Pubitemid 44062411)
32. Graff-Radford N. R., Crook J. E., Lucas J., Boeve B. F., Knopman D. S., Ivnik R. J., Smith G. E., Younkin L. H., Petersen R. C., Younkin S. G., Association of low plasma A 42/A 40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease Archives of Neurology 2007 64 3 354 362 (Pubitemid 46425689)
33. Schupf N., Tang M. X., Fukuyama H., Manly J., Andrews H., Mehta P., Ravetch J., Mayeux R., Peripheral A subspecies as risk biomarkers of Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2008 105 37 14052 14057
34. Xu W., Kawarabayashi T., Matsubara E., Deguchi K., Murakami T., Harigaya Y., Ikeda M., Amari M., Kuwano R., Abe K., Shoji M., Plasma antibodies to A 40 and A 42 in patients with Alzheimer's disease and normal controls Brain Research 2008 1219 169 179
35. Lambert J. C., Schraen-Maschke S., Richard F., Fievet N., Rouaud O., Berr C., Dartigues J. F., Tzourio C., Alpérovitch A., Buée L., Amouyel P., Association of plasma amyloid with risk of dementia: the prospective Three-City Study Neurology 2009 73 11 847 853
36. Okereke O. I., Xia W., Selkoe D. J., Grodstein F., Ten-year change in plasma amyloid levels and late-life cognitive decline Archives of Neurology 2009 66 10 1247 1253
37. Xia W., Yang T., Shankar G., Smith I. M., Shen Y., Walsh D. M., Selkoe D. J., A specific enzyme-linked immunosorbent assay for measuring -amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease Archives of Neurology 2009 66 2 190 199
38. Noguchi-Shinohara M., Tokuda T., Yoshita M., Kasai T., Ono K., Nakagawa M., El-Agnaf O. M. A., Yamada M., CSF -synuclein levels in dementia with Lewy bodies and Alzheimer's disease Brain Research 2009 1251 1 6
39. Hong Z., Shi M., Chung K. A., Quinn J. F., Peskind E. R., Galasko D., Jankovic J., Zabetian C. P., Leverenz J. B., Baird G., Montine T. J., Hancock A. M., Hwang H., Pan C., Bradner J., Kang U.N.J., Jensen P. H., Zhang J., DJ-1 and -synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease Brain 2010 133 3 713 726
40. Kasai T., Tokuda T., Ishigami N., Sasayama H., Foulds P., Mitchell D. J., Mann D. M. A., Allsop D., Nakagawa M., Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis Acta Neuropathologica 2009 117 1 55 62